ReviewAntimicrobial peptides and proteins in the innate defense of the airway surface
Introduction
Throughout the day and night, our airways are exposed to bacteria by inhalation and aspiration. Yet, despite this, the airways are usually kept sterile. This protection results from an elaborate and redundant defense network that includes components of both the innate and acquired immune systems.
When bacteria enter the airway, they encounter the innate immune system (Fig. 1). Mucus acts as a physical barrier and binds organisms for subsequent removal via mucociliary clearance and cough [1]. Below the mucus lies a thin layer of airway surface liquid (ASL) containing antimicrobial factors that kill bacteria. In addition, roaming macrophages engulf and destroy bacteria. In so doing, they and the airway epithelia release cytokines, recruiting neutrophils and other circulating cells [2]. Surfactant protein A (SP-A) and SP-D, which arise from alveoli, bind to bacteria and fungi, further enhancing clearance by neutrophils and macrophages [3]. When organisms are not rapidly disposed of, they may activate receptors such as the Toll receptor on macrophages, dendritic cells and airway epithelia, thus priming the acquired immune system [4], [5].
Table 1 contrasts the innate immune system with the more widely appreciated acquired immune system. The evolutionarily ancient innate immune system does not require previous exposure to pathogens or immunologic memory although expression of some components increases during bacterial challenge. The antibacterial peptides and proteins of the innate immune system are relatively nonspecific and rapidly kill invading microbes. In contrast, B and T cells proliferate and fine-tune the specificity of their response after pathogen exposure; thus, unlike innate responses, adaptive responses are improved upon re-exposure. The antimicrobial factors in ASL are designed to control small numbers of bacteria whereas the adaptive immune system is tailored to handle large numbers of bacteria and established infections. However, the adaptive immune response can take days and often produces inflammatory side-effects that may damage the airways. Maintenance of healthy airways requires both systems. Here, we briefly review recent work on a key component of the innate defense system, airway antimicrobial peptides and proteins.
Section snippets
Concentration and location
ASL contains a rich diversity of antimicrobial proteins and peptides; Table 2 shows several. Submucosal gland serous cells produce the bulk of these factors, with airway epithelia and neutrophils contributing to the mixture. The antibacterial factors present in the airway include proteins, such as lysozyme and lactoferrin, and peptides, such as human β-defensin 1 (HBD-1), HBD-2, LL-37 (a cathelicidin), HNPs (human neutrophil peptides) and acidic peptides as well as other small molecules.
Antimicrobial factors in airway surface liquid are part of an integrated defense system
Although most studies of ASL antimicrobial factors have focused on their individual action, it is apparent that ASL factors function together and with other components of the innate and adaptive immune system. These integrated actions are likely to increase antimicrobial potency and provide mechanisms to recruit additional components of the immune system if initial innate defenses are inadequate. Empirical support for the importance of multiple antimicrobial factors comes from studies of nasal
In vivo studies of antimicrobial factors
Nearly all studies of ASL antimicrobial peptides have been done using in vitro assays. This, plus the plethora of factors in ASL, raises the question of which factors are important to airway defense in vivo. Presumably all are important but evidence to support this assumption is minimal. One way to study the importance of individual factors would be to generate mice with disruptions in the genes encoding various airway antimicrobial factors. We expect that reports of such experiments will soon
Abnormalities of antimicrobial killing in disease
A genetic disruption of the antimicrobial defense system has been proposed to account for chronic airway infections in cystic fibrosis (CF) [31], [32]. Airway infections begin early in the course of disease with many different organisms, and then with time P. aeruginosa and Staphylococcus aureus predominate. In CF, the loss of the CFTR (CF transmembrane conductance regulator) Cl– channel may cause a higher ASL salt concentration that reduces antimicrobial potency, thereby impairing the innate
Opportunities for new therapeutic approaches in the airways
The rapid emergence of bacterial strains resistant to conventional antibiotics has hastened the search for new antimicrobial agents that could be used in the airways and elsewhere. Antimicrobial peptides are promising candidates: they kill a broad spectrum of microbes, they kill rapidly, they are relatively nonimmunogenic and resistant bacteria are uncommon [38]. Potential therapeutic peptides could be based on the defensins, cathelicidin-derived peptides or other known antimicrobial peptides
Conclusions and future prospects
It has been almost 80 years since Alexander Fleming described the bactericidal activity of lysozyme in airway secretions [49]. The renewed interest in this area now poses several questions and presents several opportunities. We do not know all the components of ASL and how they work in concert. ASL is a complex soup; we need to know what the ‘meat and potatoes’ are and how the various ‘spices’ interact and enhance the mix. We must also understand how ASL components interact with epithelial,
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
of special interest
of outstanding interest
References (54)
- et al.
Signaling mechanisms in the antimicrobial host defense of Drosophila
Curr Opin Microbiol
(2000) - et al.
Anionic antimicrobial peptide-lysozyme interactions in innate pulmonary immunity
Int J Antimicrob Agents
(1999) - et al.
defensins: endogenous antibiotics of the innate host defense response
Clin Immunol Immunopath
(1998) - et al.
CD14 dependent LPS-induced β-defensin-2 expression in human tracheobronchial epithelium
J Biol Chem
(2000) - et al.
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
Cell
(1996) - et al.
Human ß-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
Cell
(1997) - et al.
Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro
Mol Cell
(1998) - et al.
Cationic peptides: a new source of antibiotics
Trends Biotechnol
(1998) - et al.
Antimicrobial peptides in mammalian and insect host defence
Curr Opin Immunol
(1999) - et al.
Engineered salt-insensitive alpha defensins with end-to-end circularized structures
J Biol Chem
(2000)
Relationships among the composition of mucus, epithelial lining liquid, and adhesion of microorganisms
Am J Respir Crit Care Med
Innate immunity and pulmonary host defense
Immunol Rev
Collectins and pulmonary innate immunity
Immunol Rev
Innate immune recognition: mechanisms and pathways
Immunol Rev
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
Antimicrob Agents Chemother
Production of β-defensins by human airway epithelia
Proc Natl Acad Sci USA
Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria
J Clin Invest
Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
J Clin Invest
Activity of abundant antimicrobials of the human airway
Am J Respir Cell Mol Biol
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid
Am J Physiol
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages
Infect Immun
Innate antimicrobial activity of nasal secretions
Infect Immun
Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin
Infect Immun
The innate immune response of the respiratory epithelium
Immunol Rev
Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1β, but not IL-6, induce human β-defensin-2 in respiratory epithelia
Am J Respir Cell Mol Biol
Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins
Am J Physiol Lung Cell Mol Physiol
Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients
Am J Respir Crit Care Med
Cited by (129)
Deciphering the complexes of zinc ions and hen egg white lysozyme: Instrumental analysis, molecular docking, and antimicrobial assessment
2024, Spectrochimica Acta - Part A: Molecular and Biomolecular SpectroscopyExercise, Immunity, and Illness
2018, Muscle and Exercise PhysiologyJunctional Interplay in Lung Epithelial Barrier Function
2017, Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease3.15 Cell culture systems for studying biomaterial interactions with biological barriers
2017, Comprehensive Biomaterials IIOrigins of cystic fibrosis lung disease
2015, New England Journal of Medicine